(Q39211780)

10 September 2017

Lack of influence of DAT1 and DRD2 gene variants on antidepressant response in generalized anxiety disorder (English)

1 reference

10 September 2017

Sneha Narasimhan

2

0 references

author name string

Wint Thu Saung

series ordinal

1

1 reference

PubMed ID

24723432

10 September 2017

Falk W Lohoff

series ordinal

3

1 reference

10 September 2017

10 April 2014

1 reference

10 September 2017

Human Psychopharmacology

1 reference

10 September 2017

29

1 reference

10 September 2017

4

1 reference

10 September 2017

316-321

1 reference

Erotomania induced by venlafaxine: a case study

10 September 2017

1 reference

A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.

21 January 2018

1 reference

21 January 2018

1 reference

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

21 January 2018

1 reference

Prominence of the dopamine D2 short isoform in dopaminergic pathways

21 January 2018

1 reference

A 40-basepair VNTR polymorphism in the dopamine transporter (DAT1) gene and the rapid response to antidepressant treatment.

21 January 2018

1 reference

The A1 allele of the D2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics

21 January 2018

1 reference

D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder

21 January 2018

1 reference

Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder

21 January 2018

1 reference

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

21 January 2018

1 reference

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

21 January 2018

1 reference

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions

21 January 2018

1 reference

Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism

21 January 2018

1 reference

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release

21 January 2018

1 reference

Venlafaxine-induced psychotic symptoms

21 January 2018

1 reference

No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors

21 January 2018

1 reference

Pharmacogenetics of anxiolytic drugs.

21 January 2018

1 reference

The role of single nucleotide polymorphism of D2 dopamine receptor gene on major depressive disorder and response to antidepressant treatment.

21 January 2018

1 reference

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory.

21 January 2018

1 reference

Pergolide to Augment the Effectiveness of Antidepressants: Clinical Experience and a Small Double-Blind Study

21 January 2018

1 reference

The mesolimbic dopamine system as a target for rapid antidepressant action.

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HUP.2404

1 reference

10 September 2017

1 reference

PubMed ID

24723432